Senti Biosciences Holdings Shareholders Approve Merger at Annual Meeting
Senti Biosciences Holdings stockholders approved the merger agreement with ST NewCo at the reconvened annual meeting on October 15, 2026. Shareholders authorized common stock issuance upon exchange of Senti Holdings’ Senior Secured Convertible Notes. A reverse stock split ranging from 1-for-20 to 1-for-50 received appr